pyrazines has been researched along with organophosphonates in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 4 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gil, JI; López de Munain, R; Ochoa de Retana, AM; Palacios, F | 1 |
Abaya, CD; Berenson, JR; Duvivier, H; Mapes, R; Nassir, Y; Patel, R; Swift, RA; Yellin, O | 1 |
Nau, JY | 1 |
Cohen, J; Kupferschmidt, K | 1 |
Bavari, S; Cardile, AP; Mayers, DL | 1 |
Blondiaux, J; Haque, A; Hober, D | 1 |
2 review(s) available for pyrazines and organophosphonates
Article | Year |
---|---|
Current status of chemically synthesized inhibitors of Ebola virus.
Topics: Adenine; Adenosine; Amides; Antiviral Agents; Cytosine; Drug Discovery; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Organophosphonates; Patents as Topic; Purine Nucleosides; Pyrazines; Pyrrolidines | 2014 |
Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks.
Topics: Amides; Amidines; Androstenes; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antiviral Agents; Benzofurans; Cytosine; Disease Models, Animal; Disease Outbreaks; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Immune Sera; Organophosphonates; Pyrazines; RNA, Small Interfering; Stilbenes; Virus Replication | 2015 |
1 trial(s) available for pyrazines and organophosphonates
Article | Year |
---|---|
A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Drug Administration Schedule; Ethylenediamines; Humans; Maximum Tolerated Dose; Multiple Myeloma; Organophosphonates; Platelet Count; Pyrazines; Radioisotopes; Recurrence; Samarium | 2009 |
3 other study(ies) available for pyrazines and organophosphonates
Article | Year |
---|---|
Synthesis of pyrazine-phosphonates and -phosphine oxides from 2H-azirines or oximes.
Topics: Azirines; Indicators and Reagents; Magnetic Resonance Spectroscopy; Organophosphonates; Oximes; Phosphorylation; Pyrazines | 2002 |
[Ebola: three experimental clinical trials directed by MSF].
Topics: Africa, Western; Amides; Anti-Infective Agents; Clinical Trials as Topic; Cytosine; France; Health Services Accessibility; Hemorrhagic Fever, Ebola; Humans; International Cooperation; Organophosphonates; Pyrazines; Societies, Medical | 2014 |
Infectious diseases. Ebola drug trials lurch ahead.
Topics: Amides; Antibodies, Monoclonal; Antiviral Agents; Clinical Trials as Topic; Cytosine; Disease Outbreaks; Ebolavirus; Hemorrhagic Fever, Ebola; Humans; Organophosphonates; Pyrazines | 2015 |